Industry trends

Purchasing information

Home page

Industry trends

Aprotinin returns to the market or endangers public life

Aprotinin was recalled to the global market due to the results of BART research. Recently, the relevant personnel of this research said that the decision of European and Canadian regulatory authorities to allow aprotinin to return to the market or the risk of endangering public life safety exists.

2017-07-18

Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations

Today, the company announced that it signed the Third Amendment with the existing shareholders and related parties of India Gland, adjusting the transaction to: the company invested no more than US $1091.3 million to acquire about 74% of Gland's equity, including the contingent consideration paid for the listing and sale of Gland Enoxaparin in the United States, which did not exceed US $25 million. The termination date of this transaction is extended to October 3, 2017.

2017-09-20

< 1...5 6 7...9 >

Unlocking the Potential of Syntomycin: Industry Case Studies

2025-12-11

Unveiling Syntomycin: The Unsung Hero in the World of Medicine

2025-12-08

Chloramphenicol: A Deep Dive into Its Impact in the Pharmaceutical Industry

2025-12-05

The Wonders of Chloramphenicol: A Deep Dive into Its Uses and Effects

2025-12-02

Unlocking the Power of Heparin Sodium: A Game-Changer in Healthcare

2025-11-29

Understanding Heparin Sodium: The Unsung Hero of Anticoagulation

2025-11-26

图片名称

©2022 Jiangxi Runquankang Biotechnology Co., Ltd. All rights reserved

| SEO |

图片名称

图片名称

Address: Guantian Industrial Park, Chongyi , Ganzhou, Jiangxi

图片名称

Tel：0791-88610177

图片名称

Phone：15170676666

图片名称

Mail：info@rqkpharm.com

图片名称

图片名称

Scan code to view